Neurocrine’s Valbenazine fails to show benefit in largest dyskinetic cerebral palsy trial
Asahi Kasei Pharma to move R&D hub to Shonan iPark in 2027
Enveda launches Phase 1 trial for first-in-class Oral IBD therapy
Abbott’s Volt PFA System gets FDA nod
Hansa Biopharma submits FDA application for kidney transplant desensitization treatment
Niagen Bioscience secures full ownership of key NAD+ patents in major IP move
Gilead licenses Assembly Bio's investigational Herpes drugs after positive phase 1b data
FDA nod to Boehringer Ingelheim’s JASCAYD for progressive pulmonary fibrosis in adults
Ipsen acquires Simcere Zaiming’s innovative ADC SIM0613
India's First: Curapod wearable gets Class II nod for drug-free musculoskeletal pain relief
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
,_Thyrocare.jpg)
